Jeff Himawan

This profile gathers the share dealings of Jeff Himawan in Horizon Therapeutics Public Ltd Co, where the filings describe the role as board member. Between 29 April 2022 and 6 October 2023, the trades on record add up to 6 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 6 October 2023 with a transaction (€4.9M) in Horizon Therapeutics Public Ltd Co. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.